abstract |
The present invention is a novel tricyclic compound that is an AKR1C3-dependent KARS inhibitor, its preparation process, pharmaceutical compositions and agents containing it, and its use in diseases and disorders mediated by the AKR1C3-dependent KARS inhibitor. Regarding. [Selection diagram] None |